|
29
|
132
|
8gewA |
H-fabp crystal soaked in a bromo palmitic acid solution |
|
35
|
154
|
8f0yA |
Lipocalin-like milk protein-1 |
|
55
|
353
|
8saiD |
Cryo-em structure of gpr34-gi complex |
|
82
|
291
|
8saiA |
Cryo-em structure of gpr34-gi complex |
|
38
|
246
|
8saiS |
Cryo-em structure of gpr34-gi complex |
|
69
|
340
|
8saiE |
Cryo-em structure of gpr34-gi complex |
|
12
|
57
|
8saiC |
Cryo-em structure of gpr34-gi complex |
|
125
|
319
|
8gycA |
Annexin a5 protein dimer mutant |
|
130
|
319
|
8h9zA |
Annexin a5 protein mutant |
|
123
|
319
|
8h0jA |
Annexin a5 mutant |
|
43
|
136
|
7ud1A |
The crystal structure of apo monomer f57:h:h:h:r58 hcrbpii with histidine insertion in the hinge loop region at 1.3 angstrom resolution |
|
29
|
134
|
7ucnA |
The crystal structure of domain-swapped dimer q108k:t51d:a28c:l36c:f57:h:r58 mutant of hcrbpii with a histidine insertion in the hinge loop region at 1.96 angstrom resolution |
|
31
|
136
|
7ucvA |
The crystal structure of apo domain-swapped dimer q108k:t51d:a28cl36c r58:h:h:h:n59 hcrbpii with histidine insertion in the hinge loop region at 2.19 angstrom resolution |
|
31
|
136
|
7ud3A |
The crystal structure of domain-swapped dimer q108k:t51d:a28c:l36c:f57:w:w:w:r58 mutant of hcrbpii with a histidine insertion in the hinge loop region at 2.36 angstrom resolution |
|
42
|
139
|
7uczA |
The crystal structure of apo monomer f57:h:h:h:h:h:h:r58 mutant of hcrbpii with histidine insertion in the hinge loop region at 1.1 angstrom resolution |
|
31
|
136
|
7ucsA |
The crystal structure of domain-swapped dimer q108k:t51d:a28c:l36c:f57:h:h:h:r58 mutant of hcrbpii with histidine insertion in the hinge loop region at 1.92 angstrom resolution |
|
29
|
139
|
7uctA |
The crystal structure of apo domain-swapped dimer f57:h:h:h:h:h:h:r58 mutant of hcrbpii with histidine insertion in the hinge loop region at 2.5 angstrom resolution |
|
54
|
164
|
7xrdA |
Cryo-em structure of arf6 helical polymer assembled on lipid membrane |
|
35
|
175
|
8i34A |
The crystal structure of epd-bcp1 from a marine sponge |
|
30
|
175
|
8i34B |
The crystal structure of epd-bcp1 from a marine sponge |
|
10
|
25
|
8ojrA |
Solution nmr structure of alpha-synuclein 1-25 peptide in 50% tfe. |
|
63
|
140
|
8ax8A |
Human apolipoprotein e4 (apoe4) n-terminal domain (space group p3121) |
|
19
|
107
|
8p5pA |
Structure of tecpr1 n-terminal dysf domain |
|
40
|
188
|
8ornA |
Crystal structure of xanthomonas campestris pv. campestris lola-lolb complex |
|
43
|
180
|
8ornB |
Crystal structure of xanthomonas campestris pv. campestris lola-lolb complex |
|
286
|
766
|
8efrA |
Cryoem of the soluble opa1 interfaces with gdp-alfx bound from the helical assembly on a lipid membrane |
|
278
|
766
|
8efsA |
Cryoem of the soluble opa1 tetramer from the apo helical assembly on a lipid membrane |
|
30
|
134
|
7g11A |
Crystal structure of human fabp4 in complex with 2,4,6-triisopropylbenzenesulfonic acid |
|
28
|
130
|
7g13A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-5-carboxylic acid |
|
32
|
134
|
7fwhA |
Crystal structure of human fabp4 in complex with 3-[5-(3,5-dichlorophenyl)tetrazol-2-yl]propanoic acid |
|
32
|
134
|
7g1dA |
Crystal structure of human fabp4 in complex with 5-ethyl-6-(3-methoxyphenyl)-3-methyl-2-sulfanylidene-1h-pyrimidin-4-one |
|
30
|
134
|
7g0vA |
Crystal structure of human fabp4 in complex with rac-(1r,2s)-2-[[3-(trifluoromethyl)phenoxy]methyl]cyclohexane-1-carboxylic acid |
|
33
|
135
|
7fwlA |
Crystal structure of human fabp4 in complex with 5-[(3,4-dichlorophenyl)methyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one |
|
29
|
130
|
7fwvA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 6-cyclopentyl-n,5-dimethyl-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
33
|
133
|
7fzfA |
Crystal structure of human fabp4 in complex with 2-(6-methyl-4-oxo-5-phenylthieno[2,3-d]pyrimidin-3-yl)butanoic acid |
|
32
|
134
|
7g1jA |
Crystal structure of human fabp4 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dimethylthiophen-2-yl]carbamoyl]cyclohexene-1-carboxylic acid |
|
31
|
134
|
7fw2A |
Crystal structure of human fabp4 in complex with 5-[(4-chlorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazole-3-thiol |
|
32
|
133
|
7g1yA |
Crystal structure of human fabp4 in complex with 2-[(3-methoxyphenyl)sulfanylmethyl]-1,3-thiazole-4-carboxylic acid |
|
32
|
134
|
7g1rA |
Crystal structure of human fabp4 in complex with 2-[(3-ethoxycarbonylthiophen-2-yl)carbamoyl]cyclopentene-1-carboxylic acid |
|
29
|
130
|
7fy9A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-cyclopentyl-4-(4-fluorophenyl)-6-[1-(methoxymethyl)cyclopentyl]-3-methyl-5-(1h-tetrazol-5-yl)pyridine |
|
33
|
133
|
7fxmA |
Crystal structure of human fabp4 in complex with 5-cyclohexyl-2-hydroxybenzoic acid |
|
32
|
134
|
7fzoA |
Crystal structure of human fabp4 in complex with 4-oxo-3-(2-phenylethyl)-10-oxa-3-azatricyclo[5.2.1.01,5]dec-8-ene-6-carboxylic acid |
|
30
|
134
|
7g19A |
Crystal structure of human fabp4 in complex with 5-[2-(1h-tetrazol-5-yl)ethyl]-6,7,8,9,10,11-hexahydrocycloocta[b]indole |
|
34
|
133
|
7fxeA |
Crystal structure of human fabp4 in complex with 2-(9-benzyl-6-methyl-1,2,3,4-tetrahydrocarbazol-1-yl)acetic acid |
|
31
|
134
|
7fxgA |
Crystal structure of human fabp4 in complex with 2-chloro-4,6-bis(trifluoromethylsulfanyl)phenol |
|
33
|
134
|
7fzmA |
Crystal structure of human fabp4 in complex with n-(2,4-dichlorophenyl)-2-(2,6-dihydroxypyrimidin-4-yl)acetamide |
|
31
|
134
|
7fxrA |
Crystal structure of human fabp4 in complex with 2-[rac-(9r,10s)-10-benzyl-3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-9-yl]acetic acid |
|
31
|
133
|
7fyfA |
Crystal structure of human fabp4 in complex with 4-(4-fluorophenyl)-2-piperidin-1-yl-3-(1h-tetrazol-5-yl)-7,8-dihydro-5h-pyrano[4,3-b]pyridine |
|
32
|
129
|
7fy8A |
Crystal structure of human fabp1 in complex with 2-[[4-cyclopropyl-5-methyl-3-[3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl]thiophen-2-yl]carbamoyl]cyclopentene-1-carboxylic acid |
|
31
|
131
|
7fx1A |
Crystal structure of human fabp4 in complex with 2-(3-phenyl-4-piperidin-1-ylphenyl)acetic acid |
